Tokyo University Confirms Efficacy Of Existing Drug For Hereditary Liver Disease In Children
This article was originally published in PharmAsia News
Executive Summary
A Tokyo University team has confirmed in clinical studies the efficacy of a drug in the treatment of a hereditary liver disease occurring in children, progressive familial intrahepatic cholestasis type 2.